Evidence map›Paper›PMID 32375058›Full record

ArticleCell metabolism2020

Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis.

Peiwei Huangyang, Fuming Li, Pearl Lee, Itzhak Nissim, Aalim M Weljie, Anthony Mancuso, Bo Li, Brian Keith, Sam S Yoon, M Celeste Simon

Abstract readPublished Erratum
In one paragraph

Article in Cell metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Peiwei Huangyang
Fuming Li
Pearl Lee
Itzhak Nissim
Aalim M Weljie
Anthony Mancuso
Bo Li
Brian Keith
Sam S Yoon
M Celeste Simon

Funding

Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease ProgressionR35CA220483 · NCI · UNIVERSITY OF PENNSYLVANIA · PI M. CELESTE SIMON · 2017 to 2026
$9.4M
HIFs and VEGF in sarcoma progression, metastasis, and radiation responseR01CA158301 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SIMON, M. CELESTE, YOON, SAM SUNGHYUN · 2011 to 2021
$4.1M
NCI NIH HHS R01 CA158301NCI NIH HHS R35 CA220483
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32375058
PMCPMC7301686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.